ZVRA
Zevra Therapeutics, Inc.
$12.77
+0.01 (+0.08%)
At close · Jul 17
Market Cap
$754.90M
Shares
59,115,084
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| LaDuane Clifton | CFO | $3,821,924 |
| Neil F. McFarlane | CEO | $3,782,042 |
| Rahsaan W. Thompson | Chief Legal Officer, Secretary and Compliance Officer | $1,571,374 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Neil F. McFarlane | CEO | $5,355,059 |
| LaDuane Clifton | CFO | $1,450,273 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Richard Pascoe | CEO | $4,122,558 |
| Travis Mickle | CEO | $3,593,438 |
| Neil F. McFarlane | CEO | $3,445,231 |
| LaDuane Clifton | CFO | $2,263,257 |
| Joshua M. Schafer | Chief Commercial Officer | $1,814,465 |
| Christal Mickle | CEO | $1,669,956 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Travis Mickle | CEO | $2,400,356 |
| Richard Pascoe | CEO | $1,360,976 |
| LaDuane Clifton | CFO | $1,038,007 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Travis Mickle | CEO | $2,657,059 |
| Sven Guenther | Chief Scientific Officer | $1,082,153 |
| LaDuane Clifton | CFO | $1,056,212 |
| Richard Pascoe | Chairman | $712,482 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Travis Mickle | CEO | $967,979 |
| Sven Guenther | Chief Scientific Officer | $563,331 |
| LaDuane Clifton | CFO | $541,114 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Travis Mickle | CEO | $1,360,174 |
| Sven Guenther | Chief Scientific Officer | $687,731 |
| LaDuane Clifton | CFO | $664,487 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Travis Mickle | CEO | $1,423,379 |
| Sven Guenther | Chief Scientific Officer | $693,606 |
| LaDuane Clifton | CFO | $647,324 |
Key facts
CIK
1434647
CUSIP
488445206
13F (30d)
11 filings
11 filers
Visit website
Investor relations